Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy
Trends in Cancer · 2024-09 · 10 (9) · 809-824
DOI: 10.1016/j.trecan.2024.06.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024-09. Verfasst von Ancuta Jurj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Precision Medicine, Molecular Targeted Therapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Noncoding RNAs, especially miRNAs, play a pivotal role in cancer initiation and metastasis, underscoring their susceptibility to precise modulation via small molecule inhibitors. This review examines the innovative strategy of targeting oncogenic miRNAs with small drug-like molecules, an approach that can reshape the cancer treatment landscape. We review the current understanding of the multifaceted roles of miRNAs in oncogenesis, highlighting emerging therapeutic paradigms that have the potential to expand cancer treatment options. As research on small molecule inhibitors of miRNA is still in its early stages, ongoing investigative efforts and the development of new technologies and chemical matter are essential to fulfill the significant potential of this innovative approach to cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, Bolo…
- Department of Chemistry, University of Washington, Seattle, WA 98195, USA. Electronic address: varani@uw.edu.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, H…
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
- G. Harold and Leila Y. Mathers Foundation
- CLL Global Research Foundation
- Ben and Catherine Ivy Foundation
Zitieren
APA
Jurj, A., Fontana, B., Varani, G., & Calin, G. A. (2024). Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy. Trends in Cancer, 10(9), 809-824. https://doi.org/10.1016/j.trecan.2024.06.006
Vancouver
Jurj A, Fontana B, Varani G, Calin GA. Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy. Trends in Cancer. 2024;10(9):809-824. doi:10.1016/j.trecan.2024.06.006
BibTeX
@article{Jurj2024,
author = {Jurj, Ancuta and Fontana, Beatrice and Varani, Gabriele and Calin, George A},
title = {Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy},
journal = {Trends in Cancer},
year = {2024},
volume = {10},
number = {9},
pages = {809--824},
doi = {10.1016/j.trecan.2024.06.006}
}
EUVIMED